FBT Holdings List

As of Nov 18, 2024

No.	Symbol	Name	% Weight	Shares
1	EXEL	Exelixis, Inc.	4.67%	1,500,329
2	NTRA	Natera, Inc.	4.18%	302,579
3	INCY	Incyte Corporation	4.13%	595,186
4	CORT	Corcept Therapeutics Incorporated	4.11%	866,247
5	ACAD	ACADIA Pharmaceuticals Inc.	4.05%	2,637,642
6	ITCI	Intra-Cellular Therapies, Inc.	3.86%	519,450
7	ARGX	argenx SE	3.75%	73,326
8	GILD	Gilead Sciences, Inc.	3.69%	463,258
9	CPRX	Catalyst Pharmaceuticals, Inc.	3.66%	1,948,200
10	NBIX	Neurocrine Biosciences, Inc.	3.61%	340,754
11	UTHR	United Therapeutics Corporation	3.56%	109,858
12	WAT	Waters Corporation	3.52%	109,937
13	VRTX	Vertex Pharmaceuticals Incorporated	3.44%	81,697
14	ALKS	Alkermes plc	3.38%	1,361,246
15	ILMN	Illumina, Inc.	3.19%	270,396
16	RGEN	Repligen Corporation	3.15%	283,487
17	BMRN	BioMarin Pharmaceutical Inc.	3.12%	559,398
18	GMAB	Genmab A/S	3.12%	1,672,487
19	AMGN	Amgen Inc.	3.01%	119,852
20	BNTX	BioNTech SE	3.00%	326,533
21	SRPT	Sarepta Therapeutics, Inc.	2.98%	316,068
22	BIIB	Biogen Inc.	2.97%	208,905
23	ALNY	Alnylam Pharmaceuticals, Inc.	2.90%	138,414
24	MTD	Mettler-Toledo International Inc.	2.87%	27,123
25	HALO	Halozyme Therapeutics, Inc.	2.85%	742,521
26	BGNE	BeiGene, Ltd.	2.82%	166,681
27	BRKR	Bruker Corporation	2.72%	609,755
28	REGN	Regeneron Pharmaceuticals, Inc.	2.66%	38,746
29	EXAS	Exact Sciences Corporation	2.48%	554,589
30	MRNA	Moderna, Inc.	2.40%	675,135
31	n/a	Dreyfus Govt Cm Inst 289	0.14%	1,588,319
32	n/a	Securities Lending - Bnym	0.00%	1

As of Nov 18, 2024